Published online Mar 25, 2026. doi: 10.5527/wjn.v15.i1.114165
Revised: October 2, 2025
Accepted: December 16, 2025
Published online: March 25, 2026
Processing time: 182 Days and 15 Hours
Acute pyelonephritis (APN) is a significant part of the healthcare burden globally. Early risk stratification in APN is crucial to guide intensive care unit (ICU) ad
To assess the accuracy of NEWS2 and qSOFA scores in predicting ICU admission, in-hospital mortality and their role in guiding urological interventions among adults with APN.
A prospective observational study, conducted at a tertiary care centre in South India over two years, on adult patients diagnosed clinically and radiologically with APN. Comprehensive clinical, laboratory, and imaging parameters were re
The NEWS2 score ≥ 5 emerged as a robust tool, identifying nearly all patients requiring ICU admission [sensitivity, 98.1%; area under the receiver operating characteristic curve (AUC): 0.977; P < 0.05] and predicting intervention with high accuracy (AUC-0.823; P < 0.05). However, the qSOFA ≥ 2 score proved to be the silent sentinel of mor
In APN, NEWS2 (≥ 5) proved to be a pragmatic trigger for ICU triage, while qSOFA (≥ 2) better flagged in-hospital mortality. Together, they form a complementary framework as a simple, objective, and lifesaving bedside tool.
Core Tip: Acute pyelonephritis (APN) is common in urology, but existing studies on early warning scores often mix heterogeneous sepsis cohorts or emphasize stone-related or emphysematous pyelonephritis. Our prospective study is the first to focus exclusively on non-obstructive, non-emphysematous APN, a group frequently overlooked yet clinically challenging. We demonstrate that the National Early Warning Score 2 score reliably identifies patients who require intensive care unit care or urgent intervention, while the quick Sequential Organ Failure Assessment score more accurately predicts mortality. Used together, they provide a complementary dual-score framework for bedside triage and prognostication. This simple approach offers urologists and nephrologists a practical, objective tool to enhance decision-making and improve patient outcomes.
